Unraveling the Interdependent Binding Mechanism of the Transcription Factor Cbf1 and CCAN, Which Aids in Chromosome Segregation

Background
During cell division, the accurate distribution of replicated genetic information to daughter cells is fundamental to biological survival. The kinetochore, a large protein complex that physically connects chromosomes to microtubules, is a crucial structure in this process. If the kinetochore fails to function properly, chromosome segregation defects can occur, leading to potentially fatal pathological conditions such as cancer or genetic diseases. Among these, the Constitutive Centromere-Associated Network (CCAN), which directly binds to centromeric DNA and forms the scaffold for kinetochore assembly, is considered a key component of the inner kinetochore.
Until now, the scientific community has considered kinetochore assembly and gene transcription regulation as separate fields. The centromere-binding factor 1 (Cbf1), a transcription factor, has also been identified only as a transcriptional roadblock that prevents unnecessary transcription near the centromere. However, the specific molecular mechanisms that stably maintain the kinetochore structure during cell division have remained a long-standing question. In particular, the detailed assembly process that controls gene transcription activity around the kinetochore while simultaneously forming a robust protein structure has not been fully elucidated.
Key Findings
The research team, led by Dr. Sue Biggins at the Fred Hutchinson Cancer Center, used the budding yeast (Saccharomyces cerevisiae) model to reveal that the transcription factor Cbf1 and the CCAN complex form an interdependent loop that supports each other's stability. This finding was published in the international academic journal Proceedings of the National Academy of Sciences (PNAS) and has attracted attention in the scientific community. The research team used a combination of in vivo and in vitro reconstitution techniques to precisely track the physical interactions between the two molecules.
Analysis revealed that Cbf1 directly binds to Okp1, an essential component of the CCAN complex, inducing stable assembly of the inner kinetochore. This binding is not simply a case of one molecule activating the other. When Cbf1 is deficient, the binding of CCAN to the centromere is inhibited, while the CCAN complex must first be stabilized for the centromere-binding ability of Cbf1 to be maintained, indicating a complementary mechanism.
The research team confirmed this mechanism by developing a Cbf1-EW mutant model in which the interaction site between Cbf1 and Okp1 was artificially blocked. The results showed that in the mutant cells, the level of CCAN localization at the centromere was drastically reduced compared to normal cells. Furthermore, when this mutant was simultaneously introduced with another kinetochore mutant, dsn1-3A, a synthetic lethality phenomenon was observed, in which the cells died. This indicates that the Cbf1 and CCAN binding interface is essential for cell survival and maintaining genome stability.
At the same time, the researchers analyzed that this interaction is closely linked to a mechanism that suppresses the occurrence of transcription in the centromere region at unwanted times. When the physical binding of Cbf1 and CCAN is released, transcripts are indiscriminately decoded in the vicinity of the centromere. This abnormal transcription can mechanically disrupt the kinetochore structure, leading to an increase in the rate of chromosome segregation failure. As a result, Cbf1 functions not only as a transcription regulator but also as a centromere hub that physically connects kinetochore structure formation and transcription suppression.
Significance and Prospects
This discovery demonstrates that transcription regulation and chromosome structure maintenance are closely linked at the molecular level, expanding the paradigm of cell biology. The structure in which a complex that creates protein structures and a regulatory factor that controls gene expression provide complementary feedback is a new key to explaining the precision of cell division. It is expected to serve as an important stepping stone in the basic science field for elucidating the kinetochore formation process in higher organisms.
However, this study was conducted using budding yeast as the main model, so follow-up studies are needed to verify whether the same interface and feedback loop operate in mammalian cells, including humans. Since yeast and humans show some differences in the amino acid sequence of kinetochore-constituent proteins, further research is needed to elucidate the binding mechanism between homologous proteins in human cells. Identifying the molecular-level high-resolution binding structure and discovering small molecules that can control it are also challenges to be solved in the future.
Proceedings of the National Academy of Sciences, Volume 123, Issue 32, August 2026. SignificanceThe kinetochore is a multisubunit complex that links chromosomes to microtubules, ensuring accurate genome segregation during cell division, yet the functions of many components remain unclear. Here, we identify an interdependent interaction ...
This research provides specific clues for developing targeted anticancer drugs that inhibit abnormal cell division in cancer cells. Cancer cells are characterized by genetic instability and often have kinetochore defects during cell division. By designing small molecules that target the Cbf1-Okp1 interaction, the binding interface between Cbf1 and CCAN, it may be possible to develop precision therapeutics that specifically induce synthetic lethality in cancer cells. For example, a scenario in which a drug that inhibits this binding is administered to patients with specific breast or lung cancers with kinetochore mutations, selectively blocking the division of cancer cells and causing them to undergo self-destruction, is a representative example. It is also expected to be usefully applied as a key biochemical marker in the treatment of genetic diseases and the prevention and diagnosis of congenital disorders caused by chromosomal abnormalities.